Pia Kivisakk Webb, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 34 | 2018 | 3222 | 1.240 |
Why?
|
| Receptors, Chemokine | 18 | 2008 | 653 | 1.140 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 5 | 2018 | 555 | 0.700 |
Why?
|
| Interleukin-10 | 9 | 2017 | 1175 | 0.670 |
Why?
|
| Leukocytes, Mononuclear | 15 | 2004 | 1842 | 0.520 |
Why?
|
| Receptors, CCR5 | 8 | 2004 | 486 | 0.490 |
Why?
|
| Interferon-beta | 7 | 2003 | 345 | 0.460 |
Why?
|
| Probiotics | 1 | 2018 | 377 | 0.450 |
Why?
|
| Monocytes | 5 | 2018 | 2573 | 0.410 |
Why?
|
| Th17 Cells | 1 | 2017 | 793 | 0.370 |
Why?
|
| Muromonab-CD3 | 1 | 2009 | 104 | 0.330 |
Why?
|
| Central Nervous System | 8 | 2004 | 1337 | 0.310 |
Why?
|
| Phagocytes | 5 | 2004 | 296 | 0.290 |
Why?
|
| Receptors, CXCR3 | 7 | 2008 | 238 | 0.280 |
Why?
|
| Optic Neuritis | 4 | 2014 | 174 | 0.270 |
Why?
|
| CD4-Positive T-Lymphocytes | 8 | 2015 | 4371 | 0.260 |
Why?
|
| MicroRNAs | 3 | 2018 | 3796 | 0.240 |
Why?
|
| Cerebrospinal Fluid | 8 | 2006 | 544 | 0.230 |
Why?
|
| Chemotaxis, Leukocyte | 4 | 2004 | 664 | 0.230 |
Why?
|
| Dendritic Cells | 2 | 2017 | 2746 | 0.220 |
Why?
|
| T-Lymphocytes | 8 | 2017 | 10191 | 0.210 |
Why?
|
| Th1 Cells | 3 | 2017 | 1037 | 0.210 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9414 | 0.190 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2020 | 103 | 0.170 |
Why?
|
| Receptors, CCR2 | 2 | 2008 | 215 | 0.170 |
Why?
|
| RNA, Messenger | 12 | 2017 | 12787 | 0.170 |
Why?
|
| Receptors, Cholinergic | 2 | 2000 | 241 | 0.160 |
Why?
|
| Membrane Glycoproteins | 6 | 2006 | 3701 | 0.160 |
Why?
|
| Interferon-gamma | 8 | 2017 | 3159 | 0.150 |
Why?
|
| Interleukin-15 | 2 | 1999 | 185 | 0.150 |
Why?
|
| Disease Progression | 2 | 2018 | 13500 | 0.140 |
Why?
|
| Myasthenia Gravis | 2 | 2000 | 214 | 0.140 |
Why?
|
| Fumarates | 1 | 2017 | 131 | 0.140 |
Why?
|
| Up-Regulation | 4 | 2015 | 4120 | 0.140 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2020 | 386 | 0.140 |
Why?
|
| Autoantibodies | 3 | 2000 | 2123 | 0.130 |
Why?
|
| Interleukin-8 | 2 | 1999 | 696 | 0.130 |
Why?
|
| T Cell Transcription Factor 1 | 1 | 2015 | 72 | 0.130 |
Why?
|
| Cytokines | 5 | 2009 | 7390 | 0.120 |
Why?
|
| Chemokines, CXC | 3 | 2002 | 422 | 0.120 |
Why?
|
| Chemokine CCL2 | 3 | 2001 | 604 | 0.120 |
Why?
|
| Cells, Cultured | 8 | 2017 | 18962 | 0.120 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 2 | 2013 | 254 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 3 | 2009 | 9180 | 0.110 |
Why?
|
| Adult | 40 | 2020 | 221122 | 0.110 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2003 | 1805 | 0.110 |
Why?
|
| Interleukin-17 | 2 | 1999 | 911 | 0.110 |
Why?
|
| Middle Aged | 39 | 2018 | 220774 | 0.110 |
Why?
|
| Myeloid Cells | 1 | 2017 | 823 | 0.100 |
Why?
|
| Adjuvants, Immunologic | 2 | 1998 | 1036 | 0.100 |
Why?
|
| Chemokine CCL5 | 2 | 2002 | 215 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 2 | 1999 | 1475 | 0.100 |
Why?
|
| Flow Cytometry | 8 | 2004 | 5866 | 0.100 |
Why?
|
| Meningitis, Aseptic | 2 | 1999 | 59 | 0.090 |
Why?
|
| Chemokines | 3 | 2004 | 960 | 0.090 |
Why?
|
| Male | 41 | 2020 | 360621 | 0.090 |
Why?
|
| Glucosylceramides | 1 | 2009 | 28 | 0.080 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2009 | 48 | 0.080 |
Why?
|
| Lymphocytes | 2 | 2008 | 2610 | 0.080 |
Why?
|
| Chemokines, CC | 2 | 2003 | 283 | 0.080 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 1999 | 72 | 0.080 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2009 | 365 | 0.080 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 1999 | 151 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2008 | 4576 | 0.080 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 1999 | 138 | 0.080 |
Why?
|
| Female | 39 | 2018 | 392485 | 0.080 |
Why?
|
| Receptors, CCR1 | 4 | 2004 | 31 | 0.080 |
Why?
|
| Collagenases | 1 | 1999 | 222 | 0.080 |
Why?
|
| Interleukin-12 | 2 | 1998 | 583 | 0.080 |
Why?
|
| Immunologic Factors | 1 | 2017 | 1589 | 0.080 |
Why?
|
| Cell Movement | 4 | 2006 | 5202 | 0.070 |
Why?
|
| Humans | 52 | 2020 | 761326 | 0.070 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 1468 | 0.070 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2001 | 1110 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2003 | 2913 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2000 | 4355 | 0.070 |
Why?
|
| Longitudinal Studies | 4 | 2018 | 14597 | 0.060 |
Why?
|
| Interleukin-1 | 1 | 1999 | 1250 | 0.060 |
Why?
|
| Leptin | 1 | 2013 | 1595 | 0.060 |
Why?
|
| Astrocytes | 2 | 2002 | 1346 | 0.060 |
Why?
|
| Aged | 25 | 2013 | 169179 | 0.060 |
Why?
|
| Visual Acuity | 1 | 2014 | 2671 | 0.060 |
Why?
|
| Ischemic Attack, Transient | 1 | 1999 | 879 | 0.060 |
Why?
|
| Chemokine CXCL10 | 3 | 2002 | 316 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2014 | 2977 | 0.060 |
Why?
|
| Arachnoid | 1 | 2003 | 50 | 0.060 |
Why?
|
| Statistics, Nonparametric | 4 | 2017 | 2853 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2017 | 36430 | 0.050 |
Why?
|
| Interleukin-4 | 4 | 2001 | 1149 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 4173 | 0.050 |
Why?
|
| Autoimmune Diseases | 3 | 2009 | 2248 | 0.050 |
Why?
|
| Immunologic Memory | 2 | 2006 | 1359 | 0.050 |
Why?
|
| Image Enhancement | 2 | 2000 | 2884 | 0.050 |
Why?
|
| CD4-CD8 Ratio | 2 | 2003 | 114 | 0.050 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 2 | 2003 | 822 | 0.050 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 1 | 2003 | 377 | 0.050 |
Why?
|
| Endothelium, Vascular | 2 | 2004 | 4432 | 0.050 |
Why?
|
| Administration, Oral | 1 | 2009 | 4013 | 0.050 |
Why?
|
| Viral Proteins | 1 | 1998 | 1803 | 0.050 |
Why?
|
| P-Selectin | 1 | 2003 | 597 | 0.050 |
Why?
|
| Choroid Plexus | 1 | 2003 | 240 | 0.040 |
Why?
|
| Leukocytes | 2 | 2003 | 2029 | 0.040 |
Why?
|
| Aged, 80 and over | 14 | 2006 | 58946 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2006 | 831 | 0.040 |
Why?
|
| Transcription Factor TFIID | 1 | 2020 | 150 | 0.040 |
Why?
|
| Intermediate Filaments | 1 | 2020 | 172 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 2000 | 3210 | 0.040 |
Why?
|
| Brain | 5 | 2017 | 27103 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 2003 | 346 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2003 | 1125 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 6309 | 0.040 |
Why?
|
| Antibodies | 1 | 1997 | 2421 | 0.040 |
Why?
|
| Histone Acetyltransferases | 1 | 2020 | 336 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 2003 | 520 | 0.040 |
Why?
|
| CD40 Ligand | 2 | 2000 | 526 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2018 | 41440 | 0.040 |
Why?
|
| Gene Expression | 5 | 2001 | 7582 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 4550 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2003 | 1536 | 0.030 |
Why?
|
| Spinal Cord | 2 | 2017 | 1817 | 0.030 |
Why?
|
| Macrophages | 2 | 2003 | 5768 | 0.030 |
Why?
|
| Graft Rejection | 1 | 2009 | 4446 | 0.030 |
Why?
|
| Immunohistochemistry | 5 | 2004 | 11070 | 0.030 |
Why?
|
| Dystonic Disorders | 1 | 2020 | 350 | 0.030 |
Why?
|
| Chemokine CCL4 | 2 | 2001 | 126 | 0.030 |
Why?
|
| Macrophage Inflammatory Proteins | 2 | 2001 | 121 | 0.030 |
Why?
|
| Adolescent | 9 | 2017 | 88305 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 1999 | 1900 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 3806 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 1998 | 3048 | 0.030 |
Why?
|
| Myelin Sheath | 2 | 2004 | 653 | 0.030 |
Why?
|
| Microglia | 1 | 2003 | 1357 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 1998 | 7597 | 0.030 |
Why?
|
| Receptors, CCR8 | 2 | 2004 | 28 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2009 | 10431 | 0.030 |
Why?
|
| Receptors, CCR7 | 2 | 2004 | 107 | 0.030 |
Why?
|
| Immunologic Surveillance | 1 | 2003 | 92 | 0.030 |
Why?
|
| Demyelinating Autoimmune Diseases, CNS | 1 | 2002 | 38 | 0.030 |
Why?
|
| Skin | 1 | 2006 | 4482 | 0.030 |
Why?
|
| Myelitis, Transverse | 1 | 2002 | 40 | 0.030 |
Why?
|
| Immunophenotyping | 2 | 2003 | 1870 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2003 | 554 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2009 | 39108 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2004 | 2468 | 0.020 |
Why?
|
| Atrophy | 1 | 2017 | 1632 | 0.020 |
Why?
|
| Mice | 2 | 2017 | 81474 | 0.020 |
Why?
|
| Reference Values | 2 | 2000 | 4921 | 0.020 |
Why?
|
| Age of Onset | 1 | 2008 | 3303 | 0.020 |
Why?
|
| Animals | 4 | 2017 | 168388 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2006 | 4649 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2000 | 6525 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2017 | 1836 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 1999 | 306 | 0.020 |
Why?
|
| Autopsy | 2 | 2004 | 1006 | 0.020 |
Why?
|
| Acute-Phase Reaction | 1 | 1999 | 91 | 0.020 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 1999 | 72 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2000 | 6341 | 0.020 |
Why?
|
| Antigens, CD20 | 1 | 2000 | 201 | 0.020 |
Why?
|
| Measles virus | 1 | 1998 | 67 | 0.020 |
Why?
|
| Chemokine CCL3 | 1 | 1998 | 84 | 0.020 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 1998 | 133 | 0.020 |
Why?
|
| Cell Count | 1 | 2002 | 1835 | 0.020 |
Why?
|
| Perforin | 1 | 1998 | 167 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2000 | 412 | 0.020 |
Why?
|
| Creatine | 1 | 2000 | 427 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15835 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1998 | 417 | 0.020 |
Why?
|
| Aspartic Acid | 1 | 2000 | 576 | 0.020 |
Why?
|
| Antibody-Producing Cells | 1 | 1997 | 140 | 0.020 |
Why?
|
| Antigens, CD | 2 | 2004 | 4000 | 0.020 |
Why?
|
| Receptors, CCR | 1 | 2006 | 37 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 1998 | 344 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1998 | 552 | 0.020 |
Why?
|
| Receptors, CCR4 | 1 | 2006 | 77 | 0.020 |
Why?
|
| Contrast Media | 2 | 2000 | 5310 | 0.020 |
Why?
|
| Gadolinium DTPA | 1 | 1999 | 823 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1998 | 1060 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1999 | 632 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 1997 | 728 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 4850 | 0.020 |
Why?
|
| Blood Cells | 1 | 1997 | 304 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1999 | 1597 | 0.020 |
Why?
|
| Gene Expression Regulation | 2 | 2018 | 11900 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2013 | 80575 | 0.010 |
Why?
|
| Biological Assay | 1 | 1997 | 626 | 0.010 |
Why?
|
| Cell Differentiation | 2 | 2002 | 11531 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 2006 | 899 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2003 | 2203 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 293 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 1998 | 756 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 1998 | 921 | 0.010 |
Why?
|
| Immunoassay | 1 | 1997 | 746 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 2003 | 80 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2013 | 22124 | 0.010 |
Why?
|
| Venules | 1 | 2003 | 161 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2004 | 868 | 0.010 |
Why?
|
| Ligands | 1 | 2000 | 3271 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2002 | 2909 | 0.010 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2004 | 282 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1998 | 1675 | 0.010 |
Why?
|
| Integrins | 1 | 2006 | 834 | 0.010 |
Why?
|
| Time Factors | 3 | 2004 | 39974 | 0.010 |
Why?
|
| Chemokine CCL7 | 1 | 2001 | 30 | 0.010 |
Why?
|
| Chemokine CCL8 | 1 | 2001 | 17 | 0.010 |
Why?
|
| Monocyte Chemoattractant Proteins | 1 | 2001 | 47 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2006 | 1967 | 0.010 |
Why?
|
| Child | 4 | 2014 | 80156 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2018 | 26108 | 0.010 |
Why?
|
| Myelin Proteolipid Protein | 1 | 2001 | 107 | 0.010 |
Why?
|
| Myelin-Associated Glycoprotein | 1 | 2001 | 107 | 0.010 |
Why?
|
| E-Selectin | 1 | 2003 | 576 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1998 | 2206 | 0.010 |
Why?
|
| Neutrophils | 1 | 2003 | 3765 | 0.010 |
Why?
|
| Myelin Proteins | 1 | 2001 | 209 | 0.010 |
Why?
|
| Vitamin D | 1 | 2014 | 3304 | 0.010 |
Why?
|
| Inflammation | 2 | 2001 | 10760 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 1998 | 1959 | 0.010 |
Why?
|
| Electric Impedance | 1 | 2004 | 756 | 0.010 |
Why?
|
| Oligodendroglia | 1 | 2004 | 538 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2017 | 8997 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 2000 | 1665 | 0.010 |
Why?
|
| Acute Disease | 1 | 2000 | 7238 | 0.010 |
Why?
|
| Young Adult | 2 | 2017 | 59196 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2017 | 20092 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 2006 | 1994 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2004 | 1560 | 0.010 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2004 | 952 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2003 | 6571 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2003 | 1058 | 0.010 |
Why?
|
| Cell Separation | 1 | 2003 | 1722 | 0.010 |
Why?
|
| Age Factors | 1 | 2014 | 18401 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 5034 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2000 | 4764 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2003 | 3089 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 8592 | 0.010 |
Why?
|
| Temperature | 1 | 2003 | 2229 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1998 | 10764 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4567 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2445 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 6231 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2000 | 9319 | 0.010 |
Why?
|
| Cell Division | 1 | 2001 | 4466 | 0.010 |
Why?
|
| Infant | 2 | 2004 | 36202 | 0.010 |
Why?
|
| Biopsy | 1 | 2003 | 6768 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2004 | 42251 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 13446 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2001 | 3060 | 0.000 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 17640 | 0.000 |
Why?
|
| Membrane Proteins | 1 | 2004 | 7852 | 0.000 |
Why?
|
| Stroke | 1 | 1999 | 9749 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 2001 | 14409 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1999 | 54405 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2001 | 22154 | 0.000 |
Why?
|